
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $625M | -- | -- | $0.23 | -- |
08/06/2025 | Q2 | $612.6M | -- | -- | $0.21 | -- |
05/07/2025 | Q1 | $587.2M | $599M | $0.20 | $0.17 | $0.03 |
02/13/2025 | Q4 | $552.9M | $571M | $0.21 | $0.13 | $0.08 |
11/07/2024 | Q3 | $614.9M | $606M | $0.12 | $0.21 | -$0.09 |
08/07/2024 | Q2 | $634.7M | $633M | $0.21 | $0.24 | -$0.03 |
05/10/2024 | Q1 | $569.2M | $563M | $0.19 | $0.23 | -$0.04 |
02/15/2024 | Q4 | $540.8M | $555M | $1.35 | $0.16 | $1.19 |
11/02/2023 | Q3 | -- | -- | $0.32 | $0.25 | $0.07 |
08/02/2023 | Q2 | -- | -- | $0.31 | $0.25 | $0.06 |
05/04/2023 | Q1 | -- | -- | $0.28 | $0.22 | $0.07 |
02/16/2023 | Q4 | -- | -- | $0.28 | $0.21 | $0.07 |
11/02/2022 | Q3 | -- | -- | $0.35 | $0.25 | $0.10 |
08/03/2022 | Q2 | -- | -- | $0.23 | $0.17 | $0.06 |
05/05/2022 | Q1 | -- | -- | $0.27 | $0.09 | $0.18 |
02/17/2022 | Q4 | -- | -- | $0.11 | $0.03 | $0.08 |
11/03/2021 | Q3 | -- | -- | $0.05 | $0.02 | $0.03 |
08/04/2021 | Q2 | -- | -- | -$0.02 | -$0.01 | -$0.01 |
05/05/2021 | Q1 | -- | -- | -$0.09 | -$0.14 | $0.05 |
02/17/2021 | Q4 | -- | -- | -$0.40 | -$0.19 | -$0.21 |
11/04/2020 | Q3 | -- | -- | -$0.20 | -$0.24 | $0.04 |
08/05/2020 | Q2 | -- | -- | -$0.27 | -$0.31 | $0.04 |
05/06/2020 | Q1 | -- | -- | -$3.03 | -$0.06 | -$2.97 |
02/19/2020 | Q4 | -- | -- | -$1.27 | $0.01 | -$1.28 |
11/06/2019 | Q3 | -- | -- | $0.09 | $0.07 | $0.02 |
08/02/2019 | Q2 | -- | -- | $0.09 | $0.09 | $0.00 |
05/02/2019 | Q1 | -- | -- | $0.12 | $0.09 | $0.03 |
02/14/2019 | Q4 | -- | -- | $0.11 | $0.06 | $0.05 |
11/01/2018 | Q3 | -- | -- | $0.15 | $0.11 | $0.04 |
08/02/2018 | Q2 | -- | -- | $0.10 | $0.03 | $0.07 |
05/02/2018 | Q1 | -- | -- | $0.01 | -$0.02 | $0.03 |
02/14/2018 | Q4 | -- | -- | -$0.08 | -$0.05 | -$0.03 |
11/01/2017 | Q3 | -- | -- | -$0.03 | -$0.04 | $0.01 |
08/02/2017 | Q2 | -- | -- | -$0.10 | -$0.09 | -$0.01 |
05/03/2017 | Q1 | -- | -- | -$0.15 | -$0.21 | $0.06 |
02/15/2017 | Q4 | -- | -- | -$0.29 | -$0.33 | $0.04 |
11/02/2016 | Q3 | -- | -- | -- | -- | -- |
08/03/2016 | Q2 | -- | -- | -- | -- | -- |
05/04/2016 | Q1 | -- | -- | -- | -- | -- |
02/23/2016 | Q4 | -- | -- | -- | -- | -- |
11/03/2015 | Q3 | -- | -- | -- | -- | -- |
Dnow reported $599M worth of top line sales in its most recent quarter.
Dnow announced earnings per share of $0.20 which represents a beat of analyst forecast a $0.17 per share.
Dnow reported $139M that represents $1.30 per share over the last quarter.
Dnow's earnings are forecast to grow from $0.74 per share to $0.79 per share next year representing an increase of 19.37%.
Dnow's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.